Stryker made significant inroads into the spine market by acquiring K2M for $1.4 billion in late August. Since then, the company has focused on the integration and its growth strategy for the coming years, even as the spine market seems…
Spinal Tech
Implanet received CE mark approval for its Jazz Cap System.
WishBone Medical acquired Response Ortho.
A former Insys Therapeutics executive pleaded guilty for his role in a conspiracy to defraud insurers by bribing physicians to unnecessarily prescribe a fentanyl-based drug, according to NBC News.
FloSpine is a spinal implant company.
The FDA will overhaul its 510(k) clearance pathway for medical devices.
Warsaw, Ind., is known as the 'orthopedic capital of the world,' according to Wane.com, featuring Zimmer Biomet, Medtronic and DePuy Synthes manufacturing locations.
Stryker priced four senior notes offerings, totaling $2.56 billion.
Here are nine key notes from orthopedic and spine device companies in the past week.
Auris Health received $220 million in equity financing to advance the commercialization of its endobronchial Monarch Platform and robotic technology development.
